Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis
- PMID: 31734400
- DOI: 10.1016/j.autrev.2019.102430
Multiple sclerosis, the microbiome, TLR2, and the hygiene hypothesis
Abstract
The pathophysiology of autoimmune diseases such as Multiple Sclerosis (MS) involves a complex interaction between genetic and environmental factors. Studies of monozygotic twins suggest a significant role for environmental factors in susceptibility to MS. Numerous studies, driven by the "Hygiene Hypothesis," have focused on the role of environmental factors in allergic and autoimmune diseases. The hygiene hypothesis postulates that individuals living in environments that are too "clean" lack the requisite exposure to "immune-tolerizing" microbial products, resulting in poorly regulated immune systems and increased immune-mediated diseases. Interestingly, few studies have linked MS with the hygiene hypothesis. Similarly, although numerous studies have examined the role of the microbiome in autoimmune diseases, there has been no consistent documentation of disease-specific alterations in the MS microbiome. In this review, we present evidence that integrating the hygiene hypothesis and the microbiome allows for the identification of novel pathophysiologic mechanisms in MS. Our central hypothesis is that the microbiome in MS represents a "defective environment" that fails to provide normal levels of "TLR2-tolerizing" bacterial products to the systemic immune system. Consistent with the hygiene hypothesis, we posit that this defective microbiome function results in abnormally regulated systemic innate immune TLR2 responses that play a critical role in both the inflammatory and defective remyelinative aspects of MS. We have completed proof of concept studies that support the inflammatory, remyelinating, and human immune response components of this paradigm. Our studies suggest that induction of TLR2 tolerance may represent a novel approach to treating MS, inhibiting autoimmune inflammation while simultaneously facilitating remyelination.
Keywords: Hygiene hypothesis; Microbiome; Multiple sclerosis; Remyelination; TLR tolerance; TLR2.
Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.
Similar articles
-
Enhanced TLR2 responses in multiple sclerosis.Clin Exp Immunol. 2018 Sep;193(3):313-326. doi: 10.1111/cei.13150. Epub 2018 Jul 24. Clin Exp Immunol. 2018. PMID: 30043528 Free PMC article.
-
Systemic TLR2 tolerance enhances central nervous system remyelination.J Neuroinflammation. 2019 Jul 27;16(1):158. doi: 10.1186/s12974-019-1540-2. J Neuroinflammation. 2019. PMID: 31351476 Free PMC article.
-
Gut microbiome in multiple sclerosis: The players involved and the roles they play.Gut Microbes. 2017 Nov 2;8(6):607-615. doi: 10.1080/19490976.2017.1349041. Epub 2017 Aug 3. Gut Microbes. 2017. PMID: 28696139 Free PMC article. Review.
-
TLR Tolerance as a Treatment for Central Nervous System Autoimmunity.J Immunol. 2016 Sep 15;197(6):2110-8. doi: 10.4049/jimmunol.1600876. Epub 2016 Aug 8. J Immunol. 2016. PMID: 27503211
-
The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.Neurol Clin. 2018 Feb;36(1):185-196. doi: 10.1016/j.ncl.2017.08.008. Neurol Clin. 2018. PMID: 29157399 Review.
Cited by
-
Mycobacterium paratuberculosis: A HERV Turn-On for Autoimmunity, Neurodegeneration, and Cancer?Microorganisms. 2024 Sep 13;12(9):1890. doi: 10.3390/microorganisms12091890. Microorganisms. 2024. PMID: 39338563 Free PMC article. Review.
-
The known and unknown of post-pump chorea: a case report on robust steroid responsiveness implicating occult neuroinflammation.Front Immunol. 2024 Sep 10;15:1458022. doi: 10.3389/fimmu.2024.1458022. eCollection 2024. Front Immunol. 2024. PMID: 39318628 Free PMC article.
-
Game of microbes: the battle within - gut microbiota and multiple sclerosis.Gut Microbes. 2024 Jan-Dec;16(1):2387794. doi: 10.1080/19490976.2024.2387794. Epub 2024 Aug 8. Gut Microbes. 2024. PMID: 39114974 Free PMC article. Review.
-
Microbiome-derived bacterial lipids regulate gene expression of proinflammatory pathway inhibitors in systemic monocytes.Front Immunol. 2024 Jun 26;15:1415565. doi: 10.3389/fimmu.2024.1415565. eCollection 2024. Front Immunol. 2024. PMID: 38989285 Free PMC article.
-
Key Genes in Olfactory Disorder in Experimental Autoimmune Encephalomyelitis Identified by Transcriptomic Analysis of the Olfactory Bulbs.Mol Neurobiol. 2024 Aug;61(8):5771-5786. doi: 10.1007/s12035-024-03923-0. Epub 2024 Jan 17. Mol Neurobiol. 2024. PMID: 38233686
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical